2SEVENTY BIO, INC. - Annual Financials - Cash Flow (SEC)

Updated on January 3, 2026.

Related Topics: SEC Topic List.

Data Source: SEC.

See details in table below.

You can see similar for other companies.

2SEVENTY BIO, INC. - Annual Cash Flow (In Thousands of USD, Except Per Share Amounts)

Breakdown	2024-12-31	2023-12-31	2022-12-31
Net loss	-57247	-217570
Change in fair value of contingent consideration	0	235
Depreciation and amortization	7096	10285
Stock-based compensation expense	12150	32159
Goodwill impairment charge	0	12056
Gain (loss) on sale of assets	-5026	0
Other non-cash items	4620	6627
Prepaid expenses and other assets	-7918	-15735
Operating lease right-of-use assets	15567	20927
Accounts payable	-4397	-423
Accrued expenses and other liabilities	-2598	-27713
Operating lease liabilities	-12956	-13499
Deferred revenue	-535	11321
Collaboration research advancement	0	3744
Net cash used in operating activities	-84998	-166858
Purchases of property, plant and equipment	707	13865
Proceeds from sale of assets	5000	0
Proceeds from sale of equipment	176	0
Purchases of marketable securities	127466	246743
Proceeds from maturities of marketable securities	166505	304899
Purchase of restricted investments	25805	18430
Proceeds from maturities of restricted investments	25060	18000
Net cash provided by investing activities	80763	43861
Proceeds from issuance of common stock in public offering, net of issuance costs	0	117004
Proceeds from issuance of common stock to Regeneron, net of issuance costs	0	9859
Proceeds from exercise of stock options and ESPP contributions	417	527
Net cash provided by financing activities	417	127390
Increase (decrease) in cash, cash equivalents and restricted cash and cash equivalents	-3818	4393
Cash, cash equivalents and restricted cash and cash equivalents at beginning of year	0	1725	72290
Cash, cash equivalents and restricted cash and cash equivalents at end of year	0	1725	72290
Cash and cash equivalents	71244	74958
Restricted cash and cash equivalents included in restricted investments and other non-current assets	33900	1725
Total cash, cash equivalents and restricted cash and cash equivalents	0	1725	72290
Purchases of property, plant and equipment included in accounts payable and accrued expenses	0	855